1. Home
  2. BRLT vs AIMD Comparison

BRLT vs AIMD Comparison

Compare BRLT & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brilliant Earth Group Inc.

BRLT

Brilliant Earth Group Inc.

HOLD

Current Price

$1.25

Market Cap

20.6M

ML Signal

HOLD

AIMD

Ainos Inc.

HOLD

Current Price

$2.23

Market Cap

17.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRLT
AIMD
Founded
2005
1984
Country
United States
United States
Employees
N/A
41
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.6M
17.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
BRLT
AIMD
Price
$1.25
$2.23
Analyst Decision
Hold
Analyst Count
4
0
Target Price
$1.70
N/A
AVG Volume (30 Days)
75.1K
920.1K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$437,483,000.00
N/A
Revenue This Year
$6.72
N/A
Revenue Next Year
$4.95
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.63
N/A
52 Week Low
$1.11
$0.45
52 Week High
$3.10
$4.50

Technical Indicators

Market Signals
Indicator
BRLT
AIMD
Relative Strength Index (RSI) 46.09 51.97
Support Level $1.11 $1.55
Resistance Level $1.37 $2.51
Average True Range (ATR) 0.06 0.49
MACD 0.00 -0.02
Stochastic Oscillator 52.00 26.71

Price Performance

Historical Comparison
BRLT
AIMD

About BRLT Brilliant Earth Group Inc.

Brilliant Earth Group Inc is an digitally native omnichannel jewelry company selling The company's products include rings, necklaces, earrings, and bracelets. Its collection of premium-quality diamond engagement and wedding rings, gemstone rings, and fine jewelry is conceptualized by in-house design studio. The company operates in one operating and reporting segment, the retail sale of diamonds, gemstones and jewelry.

About AIMD Ainos Inc.

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.

Share on Social Networks: